IP Library Granted Patent US 12,194,216
Granted Patent B2
US 12,194,216 · App. 17/237,911 · Granted Jan 14, 2025

Methods and systems for establishing retrograde carotid arterial blood flow

Inventors: Stewart M. Kume (Sunnyvale, CA); Sieu T. Duong (Sunnyvale, CA); Michi E. Garrison (Sunnyvale, CA)
Assignee: Silk Road Medical, Inc.
A61M1/3613A61M1/3653A61M1/3656A61M1/3659A61M25/10A61M39/06A61M39/223A61M2205/3334A61M2205/7545
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,194,216
App. No.
17/237,911
Granted
Jan 14, 2025
Kind
B2
Abstract

Devices and methods establish and facilitate retrograde or reverse flow blood circulation in the region of the carotid artery bifurcation in order to limit or prevent the release of emboli into the cerebral vasculature such as into the internal carotid artery. The methods are particularly useful for interventional procedures performed through a transcarotid approach or transfemoral into the common carotid artery.

Claims (13)

1. A transcarotid access sheath system, comprising:

a distal sheath body defining an internal lumen, the sheath body sized and shaped to be introduced into an opening in a carotid artery and receive blood flow from the carotid artery;

an elongated tubing attached to a proximal end of the sheath body;

a Y-adapter at a proximal end of the elongated tubing, the Y-adapter including a hub adapted to be removably connected to a flow shunt line, the Y-adapter further including a valve positioned immediately adjacent to an internal lumen of the transcarotid access sheath system, wherein the valve regulates fluid flow out of the internal lumen of the transcarotid access sheath system relative to the hub;

a proximal extension connected to a proximal end of the adapter, the proximal extension formed of an elongated body;

a hemostasis valve at a proximal end of the proximal extension such that the proximal extension spaces apart the hemostasis valve from the adapter; and

a flush line connected to a proximal end of the proximal extension and providing a passageway for fluid to be flushed into the sheath body.

2. A transcarotid access sheath system as in claim 1 , further comprising an eyelet located adjacent a proximal region of the distal sheath.

3. A transcarotid access sheath system as in claim 1 , wherein the eyelet is positioned at a connection between the sheath body and the elongated tubing.

4. A transcarotid access sheath system as in claim 1 , wherein the valve transitions between an open state that permits flow out of the internal lumen of the transcarotid access sheath system and a closed state that blocks flow out of the internal lumen of the transcarotid access sheath system.

5. A transcarotid access sheath system as in claim 1 , wherein at least a portion of the sheath system is malleable.

6. A transcarotid access sheath system as in claim 1 , further comprising the flow shunt line.

7. A transcarotid access sheath system as in claim 6 , wherein the flow shunt line is removably connected to the hub.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2021
From: KUME, STEWART M.; DUONG, SIEU T.; GARRISON, MICHI E.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 057705/0481 →
Continuity (4)
Continuation 16299524 · Mar 12, 2019
Division 15093406 · Apr 7, 2016
Provisional Application 62145809 · Apr 10, 2015
Related Publication 20210236790A1 · Aug 5, 2021
References Cited (189)
US 4301803A · Handa et al. · 1981 [cited by applicant]
US 4493707A · Ishihara · 1985 [cited by applicant]
US 4865581A · Lundquist et al. · 1989 [cited by applicant]
US 5584803A · Stevens et al. · 1996 [cited by applicant]
US 5769830A · Parker · 1998 [cited by applicant]
US 5916193A · Stevens et al. · 1999 [cited by applicant]
US 6152912A · Jansen et al. · 2000 [cited by applicant]
US 6206868B1 · Parodi · 2001 [cited by applicant]
US 6383172B1 · Barbut · 2002 [cited by applicant]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6527746B1 · Oslund et al. · 2003 [cited by applicant]
US 6540712B1 · Parodi et al. · 2003 [cited by applicant]
US 6551268B1 · Kaganov et al. · 2003 [cited by applicant]
US 6582448B1 · Boyle et al. · 2003 [cited by applicant]
US 6595953B1 · Coppi et al. · 2003 [cited by applicant]
US 6645222B1 · Parodi et al. · 2003 [cited by applicant]
US 6673040B1 · Samson et al. · 2004 [cited by applicant]
US 6682505B2 · Bates et al. · 2004 [cited by applicant]
US 6837881B1 · Barbut · 2005 [cited by applicant]
US 6855136B2 · Dorros et al. · 2005 [cited by applicant]
US 6878140B2 · Barbut · 2005 [cited by applicant]
US 6905490B2 · Parodi · 2005 [cited by applicant]
US 6936060B2 · Hogendijk et al. · 2005 [cited by applicant]
US 7004931B2 · Hogendijk · 2006 [cited by applicant]
US 7083594B2 · Coppi · 2006 [cited by applicant]
US 7223253B2 · Hogendijk · 2007 [cited by applicant]
US 7604612B2 · Ressemann et al. · 2009 [cited by applicant]
US 7833259B2 · Boatman · 2010 [cited by applicant]
US 8157760B2 · Criado et al. · 2012 [cited by applicant]
US 8343089B2 · Chang · 2013 [cited by applicant]
US 8414516B2 · Chang · 2013 [cited by applicant]
US 8460335B2 · Carpenter · 2013 [cited by applicant]
US 8545432B2 · Renati et al. · 2013 [cited by applicant]
US 8784355B2 · Criado et al. · 2014 [cited by applicant]
US 8870805B2 · Chang · 2014 [cited by applicant]
US 9011364B2 · Criado et al. · 2015 [cited by applicant]
US 9126018B1 · Garrison · 2015 [cited by applicant]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 9669183B2 · Chang · 2017 [cited by applicant]
US 9789242B2 · Criado et al. · 2017 [cited by applicant]
US 9833555B2 · Criado et al. · 2017 [cited by applicant]
US 10039906B2 · Kume et al. · 2018 [cited by applicant]
US 10085864B2 · Chou et al. · 2018 [cited by applicant]
US 10159479B2 · Hentges et al. · 2018 [cited by applicant]
US 10238853B2 · Kume et al. · 2019 [cited by applicant]
US 10286139B2 · Criado et al. · 2019 [cited by applicant]
US 11433226B2 · Kume et al. · 2022 [cited by applicant]
US 20010044598A1 · Parodi · 2001 [cited by applicant]
US 20010044634A1 · Don Michael et al. · 2001 [cited by applicant]
US 20010049517A1 · Zadno-Azizi et al. · 2001 [cited by applicant]
US 20020087119A1 · Parodi · 2002 [cited by applicant]
US 20030069468A1 · Bolling et al. · 2003 [cited by applicant]
US 20030186203A1 · Aboud · 2003 [cited by applicant]
US 20030191474A1 · Cragg et al. · 2003 [cited by applicant]
US 20030212304A1 · Lattouf · 2003 [cited by applicant]
US 20040064179A1 · Linder et al. · 2004 [cited by applicant]
US 20050131453A1 · Parodi · 2005 [cited by applicant]
US 20050154344A1 · Chang · 2005 [cited by applicant]
US 20050154349A1 · Renz et al. · 2005 [cited by applicant]
US 20050228432A1 · Hogendijk et al. · 2005 [cited by applicant]
US 20060106338A1 · Chang · 2006 [cited by applicant]
US 20090018455A1 · Chang · 2009 [cited by applicant]
US 20090198172A1 · Garrison et al. · 2009 [cited by applicant]
US 20090254166A1 · Chou et al. · 2009 [cited by applicant]
US 20100042118A1 · Garrison et al. · 2010 [cited by applicant]
US 20100185216A1 · Garrison et al. · 2010 [cited by applicant]
US 20100204684A1 · Garrison et al. · 2010 [cited by applicant]
US 20100217276A1 · Garrison et al. · 2010 [cited by applicant]
US 20100228269A1 · Garrison et al. · 2010 [cited by applicant]
US 20110004147A1 · Renati et al. · 2011 [cited by applicant]
US 20110034986A1 · Chou et al. · 2011 [cited by applicant]
US 20110087147A1 · Garrison et al. · 2011 [cited by applicant]
US 20110125131A1 · Chang · 2011 [cited by applicant]
US 20110166496A1 · Criado et al. · 2011 [cited by applicant]
US 20110166497A1 · Criado et al. · 2011 [cited by applicant]
US 20110213459A1 · Garrison et al. · 2011 [cited by applicant]
US 20130035628A1 · Garrison et al. · 2013 [cited by applicant]
US 20130172852A1 · Chang · 2013 [cited by applicant]
US 20130197621A1 · Ryan et al. · 2013 [cited by applicant]
US 20140031682A1 · Renati et al. · 2014 [cited by applicant]
US 20140031925A1 · Garrison et al. · 2014 [cited by applicant]
US 20140046346A1 · Hentges et al. · 2014 [cited by applicant]
US 20140058414A1 · Garrison et al. · 2014 [cited by applicant]
US 20140135661A1 · Garrison et al. · 2014 [cited by applicant]
US 20140296769A1 · Hyde et al. · 2014 [cited by applicant]
US 20140296868A1 · Garrison et al. · 2014 [cited by applicant]
US 20150025616A1 · Chang · 2015 [cited by applicant]
US 20150080942A1 · Garrison et al. · 2015 [cited by applicant]
US 20150150562A1 · Chang · 2015 [cited by applicant]
US 20150174368A1 · Garrison et al. · 2015 [cited by applicant]
US 20150327843A1 · Garrison · 2015 [cited by applicant]
US 20160128688A1 · Garrison et al. · 2016 [cited by applicant]
US 20160158044A1 · Chou et al. · 2016 [cited by applicant]
US 20160166804A1 · Garrison et al. · 2016 [cited by applicant]
US 20160242764A1 · Garrison et al. · 2016 [cited by applicant]
US 20160271315A1 · Chang · 2016 [cited by applicant]
US 20160317288A1 · Rogers et al. · 2016 [cited by applicant]
US 20170043141A1 · Kume et al. · 2017 [cited by applicant]
US 20170136212A1 · Garrison et al. · 2017 [cited by applicant]
US 20170209260A1 · Garrison et al. · 2017 [cited by applicant]
US 20170296798A1 · Kume et al. · 2017 [cited by applicant]
US 20170312491A1 · Ryan et al. · 2017 [cited by applicant]
US 20170354523A1 · Chou et al. · 2017 [cited by applicant]
US 20170354803A1 · Kume et al. · 2017 [cited by applicant]
US 20170361072A1 · Chou et al. · 2017 [cited by applicant]
US 20170368296A1 · Chang · 2017 [cited by applicant]
US 20180008294A1 · Garrison et al. · 2018 [cited by applicant]
US 20180154063A1 · Criado et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20180235789A1 · Wallace et al. · 2018 [cited by applicant]
US 20180289884A1 · Criado et al. · 2018 [cited by applicant]
US 20190105439A1 · Criado et al. · 2019 [cited by applicant]
US 20190125512A1 · MacDonald et al. · 2019 [cited by applicant]
US 20190150916A1 · Hentges et al. · 2019 [cited by applicant]
US 20190175885A1 · Kume et al. · 2019 [cited by applicant]
US 20190231962A1 · Criado et al. · 2019 [cited by applicant]
US 20190254680A1 · Chang · 2019 [cited by applicant]
US 20190262530A1 · Criado et al. · 2019 [cited by applicant]
US 20190269538A1 · Chou et al. · 2019 [cited by applicant]
US 20190350568A1 · Garrison · 2019 [cited by applicant]
US 20190388654A1 · Chou et al. · 2019 [cited by applicant]
US 20200009406A1 · Garrison et al. · 2020 [cited by applicant]
US 20200015826A1 · Chang · 2020 [cited by applicant]
US 20200016321A1 · Criado et al. · 2020 [cited by applicant]
US 20200038576A1 · Garrison et al. · 2020 [cited by applicant]
US 20200054871A1 · Ryan et al. · 2020 [cited by applicant]
US 20200108221A1 · Chang · 2020 [cited by applicant]
US 20200113587A1 · Garrison et al. · 2020 [cited by applicant]
US 20200170637A1 · Garrison et al. · 2020 [cited by applicant]
US 20200171277A1 · Garrison et al. · 2020 [cited by applicant]
US 20200282127A1 · Garrison et al. · 2020 [cited by applicant]
US 20200297912A1 · Criado et al. · 2020 [cited by applicant]
CN 101267781A · 2008 [cited by applicant]
CN 103747833A · 2014 [cited by applicant]
CN 104998334A · 2015 [cited by applicant]
EP 0427429A2 · 1991 [cited by applicant]
EP 2497520A1 · 2012 [cited by applicant]
JP S59161808U · 1984 [cited by applicant]
JP H07265412A · 1995 [cited by applicant]
JP H08071161A · 1996 [cited by applicant]
JP 10052490A · 1998 [cited by applicant]
JP H10033666A · 1998 [cited by applicant]
JP 2001523492A · 2001 [cited by applicant]
JP 2002522149A · 2002 [cited by applicant]
JP 2002543914A · 2002 [cited by applicant]
JP 2003521286A · 2003 [cited by applicant]
JP 2003521299A · 2003 [cited by applicant]
JP 2005523123A · 2005 [cited by applicant]
JP 2007301326A · 2007 [cited by applicant]
JP 2009522008A · 2009 [cited by applicant]
JP 2011500286A · 2011 [cited by applicant]
WO WO9925419A · 1999 [cited by applicant]
WO WO00002617A1 · 2000 [cited by applicant]
WO WO0076390A2 · 2000 [cited by applicant]
WO WO0232495A1 · 2002 [cited by applicant]
WO WO03090831A2 · 2003 [cited by applicant]
WO WO2009012473A3 · 2009 [cited by applicant]
WO WO2014160887A2 · 2014 [cited by applicant]
U.S. Appl. No. 14/227,585, filed Mar. 27, 2014, U.S. Pat. No. 2014-0296769. [cited by applicant]
U.S. Appl. No. 15/049,637, filed Feb. 22, 2016, U.S. Pat. No. 2016-0242764. [cited by applicant]
U.S. Appl. No. 15/399,638, filed Jan. 5, 2017, U.S. Pat. No. 2017-0209260. [cited by applicant]
U.S. Appl. No. 16/171,784, filed Oct. 26, 2018, U.S. Pat. No. 2019-0125512. [cited by applicant]
U.S. Appl. No. 16/281,311, filed Feb. 21, 2019, U.S. Pat. No. 2019-0388654. [cited by applicant]
U.S. Appl. No. 16/297,348, filed Mar. 8, 2019, U.S. Pat. No. 2020-0038576. [cited by applicant]
U.S. Appl. No. 16/299,524, filed Mar. 12, 2019, U.S. Pat. No. 2019-0366070. [cited by applicant]
U.S. Appl. No. 16/353,492, filed Mar. 14, 2019, U.S. Pat. No. 2020-0009406. [cited by applicant]
U.S. Appl. No. 16/377,663, filed Apr. 8, 2019, U.S. Pat. No. 2019-0231962. [cited by applicant]
U.S. Appl. No. 16/513,030, filed Jul. 16, 2019, U.S. Pat. No. 2020-0170637. [cited by applicant]
U.S. Appl. No. 16/530,783, filed Aug. 2, 2019, U.S. Pat. No. 2020-0054871. [cited by applicant]
U.S. Appl. No. 16/544,083, filed Aug. 19, 2019, U.S. Pat. No. 2020-0171277. [cited by applicant]
U.S. Appl. No. 16/880,594, filed May 21, 2020, U.S. Pat. No. 2020-0282127. [cited by applicant]
U.S. Appl. No. 16/894,474, filed Jun. 5, 2020, U.S. Pat. No. 2020-0297912. [cited by applicant]
U.S. Appl. No. 16/906,457, filed Jun. 19, 2020, U.S. Pat. No. 2020-0397472. [cited by applicant]
U.S. Appl. No. 16/939,396, filed Jul. 27, 2020, U.S. Pat. No. 2020-0397446. [cited by applicant]
U.S. Appl. No. 16/951,767, filed Nov. 18, 2020, U.S. Pat. No. 2021-0145453. [cited by applicant]
U.S. Appl. No. 16/999,634, filed Aug. 21, 2020, U.S. Pat. No. 2020-0375728. [cited by applicant]
U.S. Appl. No. 16/999,640, filed Aug. 21, 2020, U.S. Pat. No. 2020-0375729. [cited by applicant]
U.S. Appl. No. 17/000,004, filed Aug. 21, 2020, U.S. Pat. No. 2020-0390438. [cited by applicant]
U.S. Appl. No. 17/074,299, filed Oct. 19, 2020, U.S. Pat. No. 2021-0205571. [cited by applicant]
PCT/US2020/058365, Oct. 30, 2020, WO 2021/087363. [cited by applicant]
PCT/US2020/058588, Nov. 2, 2020, WO 2021/087480. [cited by applicant]
PCT/US2020/061073, Nov. 18, 2020, WO 2021/102011. [cited by applicant]
Bettmann, M. et al., “Carotid Stenting and Angioplasty: a Statement for Healthcare Professionals From the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology and Prevention, … [cited by applicant]
Henry et al. (1999) “Carotid stenting with cerebral protection: First clinical experience using the PercuSurge GuardWire System.” J. Endovasc. Surg. 6:321-331. [cited by applicant]
Ohki, M.D., et al., “Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: An experimental analysis,” J Vasc Surg 2001; 33:504-9. [cited by applicant]
Ribo, et al., “Transcranial Doppler Monitoring of Transcervical Carotid Stenting with Flow Reversal Protection: A Novel Carotid Revascularization Technique”, Stroke 2006, 37, 2846-2849. [cited by applicant]
Stejskal et al., “Experience of 500 Cases of Neurophysiological Monitoring in Carotid Endarterectomy,” Acta Neurochir, 2007, 149:681-689. [cited by applicant]
Choudhry, F. A. (2016, E-pub Aug. 3, 2015). “Vascular geometry of the extracranial carotid arteries: an analysis of length, diameter, and tortuosity.” Journal of Neurointerventional Surgery, 8(5), 536-540. XP093041852, … [cited by applicant]